[Long-term application of percutaneous cardiopulmonary support system without systemic heparinization].
Though the amount of systemic heparin sodium administration was reduced after the introduction of heparin sodium-coating material to percutaneous cardiopulmonary support system (PCPS), bleeding due to heparin sodium is still the one of the major complications. In 2 patients of postcardiotomy cardiogenic shock, we neutralized heparin sodium by protamine sulfate administration immediately after the institution of PCPS and did not perform systemic heparinization until hemostasis was secured. The time on PCPS without heparin sodium was 37 hours in 1 patient and 91 hours in another patient. While systemic heparin sodium was not administered, activated clotting time (ACT) ranged from 109 to 148 sec and the bypass flow rate was maintained in more than 2.5 l/min. The exchange of the devices was unnecessary during the assistance and the patients were successfully weaned from PCPS without major complications. We conclude that systemic anticoagulation can be avoided in the case of life-threatening hemorrhage.
Department of Cardiovascular Surgery, Tohoku Koseinenkin Hospital, Sendai, Japan.
M
M
Miura
T
T
Fukuju
D000368:Aged; D002315:Cardiopulmonary Bypass; D013504:Cardiovascular Surgical Procedures; D020099:Coated Materials, Biocompatible; D005260:Female; D006493:Heparin / Q000009:adverse effects*; D006494:Heparin Antagonists / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011183:Postoperative Complications; D011379:Prognosis; D011479:Protamines / Q000627:therapeutic use; D012770:Shock, Cardiogenic / Q000188:drug therapy* / Q000209:etiology*; D013997:Time Factors
D020099:Coated Materials, Biocompatible; D006494:Heparin Antagonists; D011479:Protamines; D006493:Heparin